Needham Cuts Price Target on Centrus Energy But Keeps Buy Rating, Citing US Uranium Enrichment Shortage

Needham analyst Carter Goman is standing behind Centrus Energy (NYSE: LEU) even as he lowered his price target on the stock.

Goman cut his target to $264 from $314 while reaffirming a Buy rating, according to a Needham research note. Centrus shares were recently trading around $171, meaning Goman's revised target still implies substantial upside if his thesis plays out. Needham's own commercial relationship with companies it covers is standard disclosure territory.

Why the Stock Has Lagged

Goman attributes the stock's underperformance against the broader market this year to three things: heavy capital spending tied to the company's planned Piketon, Ohio enrichment expansion, enrichment economics that look less impressive once compared to established competitors Urenco and Orano, and investor skepticism about how fast new nuclear reactors will actually get built.

That skepticism is not unreasonable. Nuclear construction projects in the US have a long history of running over budget and behind schedule, from Georgia's Vogtle expansion to the abandoned V.C. Summer project in South Carolina. Betting on a wave of new reactor demand to absorb enrichment capacity assumes those projects show up on time. They haven't always.

The Bull Case: A Structural Deficit

Goman's bullish argument rests on Centrus as the only US-domiciled uranium enrichment company and the only Western producer to have demonstrated high-assay low-enriched uranium (HALEU) production capability. HALEU is the specialized fuel needed for many small modular and advanced reactor designs now in development.

Russian enriched uranium, long a major supplier to US utilities, is being phased out under the Prohibiting Russian Uranium Imports Act, which Congress passed and President Biden signed in 2024. That law is tightening global supply of low-enriched uranium (LEU) at the same time demand from next-generation reactors is expected to grow.

Goman says Centrus has a credible path to reach at least 3.5 million separative work units (SWU) of enrichment capacity, which would shift the company from largely trading LEU sourced elsewhere to running its own vertically integrated enrichment operation with higher margins.

The Backlog and Federal Money

Centrus reported a $3.9 billion order backlog as of the first quarter of 2026, with contracts extending out to 2040, according to the Needham note. The LEU segment makes up $3.1 billion of that, including $2.4 billion in commitments from South Korean customers tied to future Piketon production. Those commitments, previously contingent, are now locked in as definitive agreements.

The company's Technical Solutions segment, which includes government and research work, accounts for another $800 million of the backlog.

Federal backing is a real factor here. Earlier this year the Department of Energy awarded a $900 million task order to American Centrifuge Operating, a Centrus subsidiary, under the government's HALEU Production Contract. That kind of direct federal procurement gives Centrus revenue visibility that most small-cap industrials don't have. It also means the company's fortunes are tied to continued government appetite for domestic nuclear fuel investment, which can shift with budget priorities.

What's Actually Unresolved

The core uncertainty Goman flags himself is timing. Piketon is described as a first-of-a-kind project, and FOAK projects in the nuclear sector are notorious for cost overruns and schedule slips. Whether Centrus can execute on that build-out on anything close to its projected timeline is the open question that will determine whether the $3.9 billion backlog actually converts into the earnings growth Goman is modeling.

Investors will get a clearer read as Centrus reports progress on Piketon construction milestones and additional HALEU contract awards from the Department of Energy in the coming quarters. Until then, the enrichment deficit Goman describes is a real structural trend backed by the 2024 Russian uranium import ban. How much of it Centrus captures, and how fast, remains unproven on the ground.